IRIS
MARTORA, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 541
AS - Asia 275
NA - Nord America 230
AF - Africa 7
SA - Sud America 2
OC - Oceania 1
Totale 1.056
Salva come PNG Salva come JPEG
Nazione #
DE - Germania 390
US - Stati Uniti d'America 224
SG - Singapore 211
IT - Italia 95
CN - Cina 30
FI - Finlandia 22
IN - India 21
IE - Irlanda 8
ES - Italia 7
FR - Francia 7
CI - Costa d'Avorio 6
JP - Giappone 5
RS - Serbia 5
MX - Messico 4
BR - Brasile 2
CA - Canada 2
GB - Regno Unito 2
HK - Hong Kong 2
ID - Indonesia 2
NL - Olanda 2
PK - Pakistan 2
AU - Australia 1
BE - Belgio 1
DZ - Algeria 1
GR - Grecia 1
IL - Israele 1
RO - Romania 1
TR - Turchia 1
Totale 1.056
Salva come PNG Salva come JPEG
Città #
Singapore 172
Krefeld 113
Bad Bellingen 50
Santa Clara 40
Ashburn 28
Naples 22
Lappeenranta 18
Rome 10
Dublin 8
Milan 8
Kronberg 7
Pune 6
Kochi 5
Turin 5
Boardman 4
Council Bluffs 4
Florence 4
Helsinki 4
Mexico City 4
Qingdao 4
Xi'an 4
Zhengzhou 4
Freiburg im Breisgau 3
Los Angeles 3
New Delhi 3
Nuremberg 3
Roccasecca 3
Rottweil 3
Seattle 3
Tokyo 3
Amsterdam 2
Angri 2
Arezzo 2
Bad Durrheim 2
Bhundsi 2
Castellammare di Stabia 2
Chennai 2
Corteolona 2
Formia 2
Jakarta 2
Lecce 2
London 2
Mumbai 2
New York 2
Paris 2
Pescara 2
Sarno 2
Schoenwalde 2
Shenzhen 2
Sialkot 2
Treviso 2
Utsunomiya 2
Affing 1
Belgrade 1
Boulder 1
Brussels 1
Caivano 1
Camisano Vicentino 1
Chicago 1
Cologne 1
Coquitlam 1
Dallas 1
Delhi 1
Fisciano 1
Gallatin 1
Gorgonzola 1
Hachenburg 1
Kunming 1
Mariglianella 1
Oran 1
Perth 1
Portland 1
Porto Alegre 1
Saint-Martin-d'Hères 1
Salerno 1
Sant'Anastasia 1
Seville 1
São Paulo 1
Victoria 1
Wilmington 1
Yinchuan 1
Totale 621
Salva come PNG Salva come JPEG
Nome #
Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study 324
Injection site reactions after dupilumab or tralokinumab for atopic dermatitis 32
Effect of Dupilumab on Sexual Desire in Adult Patients with Moderate to Severe Atopic Dermatitis 27
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients 25
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review 22
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients 21
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature 20
Letter to the editor regarding article "Falotico JM, Gu L, Lipner SR. Not just pimple popping: The utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID-19 pandemic. J Cosmet Dermatol. 2022;10.1111/jocd.15256" 19
Viral Reactivation Following COVID-19 Vaccination: a review of the current literature 17
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a psoriasis patient. Comment on "Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab" 16
Tattooing and hidradenitis suppurativa: stigmatization and camouflage 15
Herpes Zoster and COVID-19 Vaccination: A Narrative Review 15
Very low-calorie ketogenic diet (VLCKD) in the management of hidradenitis suppurativa (Acne Inversa): an effective and safe tool for improvement of the clinical severity of disease. Results of a pilot study 15
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data 15
Efficacy and safety of deucravacitinib for the management of psoriasis: a drug safety evaluation 15
Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasis 15
New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge 15
Efficacy and Safety of bimekizumab in psoriasis management in real-life: bio-naïve vs bio-experienced 14
Comment on: "Associations between hidradenitis suppurativa and dermatological conditions in adults: A national cross-sectional study by Brown et al." 14
Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis 13
Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature 13
Risk Factors for Psoriasis Flares: A Narrative Review 12
Effectiveness and Safety of Upadacitinib for Adolescents with Atopic Dermatitis in a Real-World Setting 12
Author Reply to “Comment on ChatGPT and Medical Writing in Dermatology: why should we keep writing?” by Daungsupawong et al 12
Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection 12
Comment on: “Clinical characteristics of patients with pityriasis rubra pilaris following SARS‐CoV‐2 vaccination” by Gambichler 12
Oral Minoxidil for Chemotherapy-Induced Alopecia 12
Long-Term Efficacy and Safety of Guselkumab in Psoriasis Patients Who Failed Anti-IL17: A Two-Year Real-Life Study 12
ChatGPT and Dermatology: friends or foes? 11
Reply to Borgia et al. Comment on “Marasca et al. Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications. J. Clin. Med. 2022, 11, 1511” 11
The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials 11
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience 11
Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature 10
Comment on 'Development of Chilblains Lesions During the COVID-19 Pandemic is Strongly Associated with Cold Weather: Retrospective Analysis of Patients from a Single Center in the United States' 10
Author Reply to “Comment on ChatGPT and Medical Writing in Dermatology: why should we keep writing?” by Duff et al 10
Comment on ‘Pityriasis rubra pilaris-like eruption following mRNA COVID-19 vaccine’ 10
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future? 10
Reply to “Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa” 10
Advancing Dermatology: Embracing the Power of Artificial Intelligence 10
Reply to 'Omalizumab for the management of refractory aquagenic pruritus' 10
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab 10
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature 9
How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis 9
Comprehensive Molecular Analysis of Disease-Related Genes as First-Tier Test for Early Diagnosis, Classification, and Management of Patients Affected by Nonsyndromic Ichthyosis 9
Airborne allergic contact dermatitis "by proxy" due to budesonide 9
Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation 9
The Past, the Present and the Future of Teledermatology: A Narrative Review 9
Guselkumab-induced vitiligo in a patient with psoriatic arthritis 8
Biologics for the Management of Erythrodermic Psoriasis: An Updated Review 8
Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19 8
Comment on ‘Anogenital dermatology: challenges in the digital era’ 8
Dietary intervention in acne management: review of the literature and future prospective 7
Allergic contact dermatitis to petrolatum: An unknown for patch testing 7
Unaddressed Challenges in the Treatment of Cutaneous Melanoma? 7
Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report 7
An update on the current and emerging pharmacotherapies for basal cell carcinomas 7
The role of teledermatology for the long-term management of stable psoriasis treated with biologics: a survey-based study 7
Comment on ‘Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease’ 7
Management of Advanced Invasive Melanoma: New Strategies 7
Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review 7
Management of Psoriasis Patients with Serious Infectious Diseases 6
Comment on ‘Permethrin-unresponsive scabies in London, UK: a wake-up call’ 6
The Impact of Psoriasis Treatments on the Risk of Skin Cancer: A Narrative Review 6
Comment on ‘Eosinophilic pustular folliculitis developing at the site of COVID-19 vaccination’ 6
Bimekizumab treatment in patients with moderate to severe plaque psoriasis: a drug safety evaluation 6
Reply to “Dalbavancin for the treatment of severe hidradenitis suppurativa” 6
ChatGPT and Medical Writing in Dermatology: why should we keep writing? 6
L-Lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Response to Letter] 5
Efficacy and Safety of Cemiplimab for the Management of Non-Melanoma Skin Cancer: A Drug Safety Evaluation 5
ChatGPT and dermatology 5
Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments 5
Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities 5
Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study 5
Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study 5
Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era? 5
Lichen planus following Covid-19 vaccination: a narrative review 4
Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report 4
Comment on ‘Oral ivermectin to treat scabies: a comparison of two different regimens’ 3
Hidradenitis Suppurativa in Elderly Patients: Clinical and Therapeutical Outcomes—A Review of the Literature 2
Effectiveness, Safety, and Long-Term Continuation Rate Analysis of Dupilumab Treatment in Adolescents with Atopic Dermatitis: A Single-Center Real-Life Retrospective Study 2
Totale 1.146
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.220
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202383 0 0 0 0 0 10 11 17 3 16 17 9
2023/2024720 13 22 50 18 11 24 16 42 331 40 77 76
2024/2025343 104 158 35 31 15 0 0 0 0 0 0 0
Totale 1.146